Bio

Dr. Rasouli is a board-certified anesthesiologist specializing in pain management. He practices at Stanford Health Care – ValleyCare in Pleasanton. He is also a clinical assistant professor in the Stanford University School of Medicine Department of Anesthesiology, Perioperative & Pain Medicine.

Dr. Rasouli takes pride in developing a comprehensive, compassionate treatment plan personalized to each patient in his care. His goals are to
relieve patients’ chronic pain, and enable them to enjoy the best possible
quality of life. In addition to his clinical practice, Dr. Rasouli has conducted research and published extensively. He was a postdoctoral research fellow at the Rothman Institute of Orthopaedics at Thomas Jefferson University in Philadelphia.

Dr. Rasouli has presented the findings of his research at conferences such as the North American Neuromodulation Society Annual Meeting, American Society of Regional Anesthesia and Pain Medicine Meeting, American Society of Anesthesiology Annual Meeting, International Anesthesia Research Society Annual Meeting, and Society of Critical Care Anesthesiologists Annual Meeting. Topics have included using spinal cord and peripheral nerve stimulation for treatment of pain, perioperative pain management, and post-surgical recovery.

He has published more than 100 articles in the peer-reviewed journals Anesthesiology, Anesthesia and Analgesia, Neurosurgery, Lancet, JAMA, Annals of Surgery, and elsewhere. He also has co-authored chapters in Spine Trauma, Epidemiology of Spinal Cord Injuries, Pain Management Following Total Hip Arthroplasty and Total Knee Arthroplasty, and Epidemiology, Diagnosis and Treatment of Sciatica, and other textbooks.

Dr. Rasouli has earned numerous honors including the Dr. Jeffrey and Celia Joseph Anesthesiology Scholarly Achievement Award. He is a member of the American Society of Anesthesiologists, California Society of Anesthesiologists, American Society of Regional Anesthesia and Pain Medicine, North American Neuromodulation Society, American Society of Pain and Neuroscience, and Society of Critical Care Medicine.

Clinical Focus

  • Pain Management

Academic Appointments

Professional Education

  • Board Certification: National Board of Echocardiography, Advanced Perioperative Transesophageal Echocardiography (2020)
  • Fellowship: Duke University School of Medicine (2019) NC
  • Residency: Thomas Jefferson University Hospital Dept of Anesthesiology (2018) PA
  • Board Certification: American Board of Anesthesiology, Pain Management (2020)
  • Board Certification: American Board of Anesthesiology, Anesthesia (2019)
  • Fellowship: Stanford University Division of Pain Medicine (2020) CA
  • Board Certification: American Board of Anesthesiology, Critical Care Medicine (2019)
  • Internship: Mercy Catholic Medical Center Transitional Year (2015) PA
  • Medical Education: Tehran University of Medical Sciences (2008) Iran

Contact

  • Academic
    rasouli1@stanford.edu
    University - Academic staff Department: Anesthesia Position: Clinical Assistant Professor
  • Clinical (Primary)  Pain Management 300 Pasteur Dr Rm A408 MC 5340 Stanford, CA 94305 (650) 721-3417 (fax)

Additional Clinical Info

Additional Info

  • Mail Code: 5640

All Publications

  • Transdermal Lidocaine for Perioperative Pain: a Systematic Review of the Literature. Current pain and headache reports Smoker, J. n., Cohen, A. n., Rasouli, M. R., Schwenk, E. S. 2019; 23 (12): 89

    Abstract

    The purpose of this review is to provide a summary of the perioperative studies that have examined transdermal lidocaine (lidocaine patch) as an analgesic and put the evidence in context of the likely overall benefit of transdermal lidocaine in the perioperative period.Several randomized controlled trials have been published in the past 4 years that concluded transdermal lidocaine can reduce acute pain associated with laparoscopic trocar or cannula insertion. Transdermal lidocaine may reduce short-term pain after surgery in selected surgery types and has a low risk of toxicity but its overall clinical utility in the perioperative setting is questionable. Transdermal lidocaine does not consistently reduce opioid consumption after surgery and has not been shown to improve patient function.

    View details for DOI 10.1007/s11916-019-0830-9

    View details for PubMedID 31728770